1. Home
  2. ICG vs ONCY Comparison

ICG vs ONCY Comparison

Compare ICG & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intchains Group Limited

ICG

Intchains Group Limited

HOLD

Current Price

$1.42

Market Cap

81.4M

Sector

Technology

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.47

Market Cap

80.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICG
ONCY
Founded
2017
1998
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.4M
80.5M
IPO Year
2022
2002

Fundamental Metrics

Financial Performance
Metric
ICG
ONCY
Price
$1.42
$0.47
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$2.00
★ $4.16
AVG Volume (30 Days)
286.3K
★ 1.2M
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$109.44
N/A
P/E Ratio
$6.80
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.44
52 Week High
$2.28
$1.32

Technical Indicators

Market Signals
Indicator
ICG
ONCY
Relative Strength Index (RSI) 70.03 29.53
Support Level $1.41 $0.44
Resistance Level $2.22 $0.89
Average True Range (ATR) 0.15 0.06
MACD 0.03 0.00
Stochastic Oscillator 84.07 19.16

Price Performance

Historical Comparison
ICG
ONCY

About ICG Intchains Group Limited

Intchains Group Ltd is an inventive altcoins development company that engages in the provision of altcoin mining products, the strategic acquisition and holding of Ethereum-based cryptocurrencies and the active development of inventive Web3 applications. The company offers high-performance mining products including altcoin mining machines incorporating its ASIC chips that have high computing power and superior power efficiency, ASIC chips and ancillary software and hardware, all of which cater to the evolving needs of the blockchain industry. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: